FDA declined to appeal a court ruling invalidating its 2024 LDT rule, concluding its push to expand regulatory control over lab-developed tests.
In Sigray v. Zeiss, the Federal Circuit reversed a PTAB ruling, holding that an implicit claim construction error led to wrongly upholding X-ray imaging patent claims.
A Ninth Circuit panel heard arguments on whether to revive a proposed class action alleging misleading expiration labels on Monsanto’s Roundup products, with some skepticism toward claims against a...
A federal jury in Texas ruled in favor of Charter Communications, rejecting a $1 billion patent infringement claim from Touchstream over a device enabling video casting to larger screens.
